Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
By R. Lu, Xiang-rong Zhao, Juan Li, P. Niu, Bo Yang, Honglong Wu, Wenling Wang, Hao Song, Baoying Huang, N. Zhu and 25 more. The Lancet, 2020
10,768 citations recorded by the source corpus.
Background In late December, 2019, patients presenting with viral pneumonia due to an unidentified microbial agent were reported in Wuhan, China. A novel coronavirus was subsequently identified as the causative pathogen, provisionally named 2019 novel coronavirus (2019-nCoV). As of Jan 26, 2020, more than 2000 cases of 2019-nCoV infection have been confirmed, most of which involved people living in or visiting Wuhan, and human-to-human transmission has been confirmed. Methods We did next-generation sequencing of samples from bronchoalveolar lavage fluid and cultured isolates from nine inpatients, eight of whom had visited the Huanan seafood market in Wuhan. Complete and partial 2019-nCoV genome sequences were obtained from these individuals. Viral contigs were connected using Sanger sequencing to obtain the full-length genomes, with the terminal regions determined by rapid amplification of cDNA ends. Phylogenetic analysis of these 2019-nCoV genomes and those of other coronaviruses was used to determine the evolutionary history of the virus and help infer its likely origin. Homology modelling was done to explore the likely receptor-binding properties of the virus. Findings The ten genome sequences of 2019-nCoV obtained from the nine patients were extremely similar, exhibiting more than 99·98% sequence identity. Notably, 2019-nCoV was closely related (with 88% identity) to two bat-derived severe acute respiratory syndrome (SARS)-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21, collected in 2018 in Zhoushan, eastern China, but were more distant from SARS-CoV (about 79%) and MERS-CoV (about 50%). Phylogenetic analysis revealed that 2019-nCoV fell within the subgenus Sarbecovirus of the genus Betacoronavirus, with a relatively long branch length to its closest relatives bat-SL-CoVZC45 and bat-SL-CoVZXC21, and was genetically distinct from SARS-CoV. Notably, homology modelling revealed that 2019-nCoV had a similar receptor-binding domain structure to that of SARS-CoV, despite amino acid variation at some key residues. Interpretation 2019-nCoV is sufficiently divergent from SARS-CoV to be considered a new human-infecting betacoronavirus. Although our phylogenetic analysis suggests that bats might be the original host of this virus, an animal sold at the seafood market in Wuhan might represent an intermediate host facilitating the emergence of the virus in humans. Importantly, structural analysis suggests that 2019-nCoV might be able to bind to the angiotensin-converting enzyme 2 receptor in humans. The future evolution, adaptation, and spread of this virus warrant urgent investigation. Funding National Key Research and Development Program of China, National Major Project for Control and Prevention of Infectious Disease in China, Chinese Academy of Sciences, Shandong First Medical University.
Subfields: Animal Science and Zoology, Immunology, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/cd99e395e1990023c1e0a373f39ce7b10561e6a6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Animal Science and Zoology
In Immunology
In Infectious Diseases
Citations in the corpus
- Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum (2021, neutral): “Since the first sequence of SARS-CoV-2 was deposited in early January 2020 (Lu et al., 2020), viral genome sequencing efforts have been established in a number of countries to track the evolution of the virus (COVID-19 Genomics UK (COG-UK) Consortium, 2020).”
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 (2020, neutral): “2c) [25] [26] [27] .”
- Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic (2020, background): “Across a large region of its genome, corresponding approximately to ORF1b , it did not cluster with any of the known bat coronaviruses indicating that recombination likely played a role in the evolutionary history of these viruses (Lu et al., 2020; Wu et al.”
- Transmission dynamics and evolutionary history of 2019‐nCoV (2020, background): “As reported in earlier research, however, although bats could be the original host of 2019‐nCoV, the virus may have initially been transmitted to an intermediate animal host sold at the Wuhan Huanan Seafood Wholesale Market, thus facilitating the emergence of 2019‐nCoV in humans.(19) In the present ”
- SARS-CoV-2: A Storm is Raging. (2020, neutral): “SARS-CoV-2 is closely related to two bat-derived SARS-like coronaviruses and SARS-CoV in phylogenetic distance (11).”
- Genotype and phenotype of COVID-19: Their roles in pathogenesis (2020, background): “This figure is modified from the sequence comparison and genomic organization of 201 9-nCoV, 2020(9).”
- Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV (2020, background): “Both SARS-CoV-2 and SARS-CoV are in the coronavirus family, β-coronavirus genera [89].”
- Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues (2020, background): “Like SARS-related coronavirus (SARS-CoV) [5] , SARS-CoV-2 uses the angiotensin-converting enzyme 2 (ACE2) as a host cell receptor [6] [7] [8] .”
- Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review (2020, result): “The results of this next-generation sequencing indicated that SARS-CoV-2 was more distant from SARS-CoV (with about 79% sequence identity) and MERS-CoV (with about 50% sequence identity) than from two bat-derived SARS-like coronavirusesbat-SL-CoVZC45 (with 87.9% sequence identity) and bat-SL-CoVZXC2”
- Principal component analysis to study the relations between the spread rates of COVID-19 in high risks countries (2020, neutral): “Background In the last months of 2019, the scientist reported a new type of coronavirus, called 2019-nCoV (or Covid-19), in Wuhan [1].”
- Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes (2020, background): “Considering SARS-CoV-2 utilizes angiotensin-converting enzyme 2 (ACE2) to bind and gain entry to infected cells (Hoffmann et al., 2020; Lu et al., 2020) and reduces the expression of ACE2 (Kuba et al.”
- Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection (2020, background): “2 Through 1 April 2020, the rapid spread of COVID-19 has impacted more than 200 countries with more than 900000 laboratoryconfirmed cases and 45000 deaths (with high numbers in China, United States, Spain, and Italy).”
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. (2020, background): “quartile range) interval from symptom onset to hospital admission is 7 (3-9) days.”
- A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 (2020, result): “, 2020), especially the receptor-binding domains of SARS-CoV is structurally similar to that of SARS-CoV-2 (Lu et al., 2020).”